Search
Get in touch!
Linkedin X-twitter Envelope

Matthew McLennan: How to build Resilience Into Your Portfolio

In this article, Matthew McLennan and Kimball Brooker from First Eagle describe how they build resilience into their portfolios and why they think that’s particularly important today. They also share their thoughts on why they tend to be slow to trade and what they think the market is missing today in some of their portfolio companies: Haleon, Shimano, Itaúsa, Douglas Emmett and ONEOK.

Here are the key takeaways

  • Value investing requires patience and discipline: Successful value investors must have the fortitude to stick to their principles even during challenging market conditions. They need to be willing to hold positions for the long term and not be swayed by short-term market fluctuations.
  • Focus on fundamentals, not market sentiment: Value investors should concentrate on a company’s underlying business fundamentals, such as earnings, cash flows, and competitive advantages, rather than getting caught up in market hype or sentiment.
  • Maintain a margin of safety: By purchasing securities at a significant discount to their intrinsic value, value investors provide themselves with a “margin of safety” that helps protect against permanent capital losses and improves potential long-term returns.
  • Be contrarian when necessary: Value investors often need to go against the crowd and invest in out-of-favor companies or sectors. This contrarian approach requires independent thinking and the ability to resist conforming to popular market opinions.
  • Continuously learn and adapt: While the core principles of value investing remain constant, investors must be willing to learn from their mistakes, adapt to changing market conditions, and refine their processes over time to remain successful in the long run.

Our gold-related assets and cash provide liquidity that allows us to be a beneficiary rather than victim of volatility.

Click here to go to the external source.

Share the news

Disclaimer of liability

The above has been prepared by Børsgade ApS for information purposes and cannot be regarded as a solicitation or recommendation to buy or sell any security. Nor can the information etc. be regarded as recommendations or advice of a legal, accounting or tax nature. Børsgade cannot be held liable for losses caused by customers’/users’ actions – or lack thereof – based on the information in the above. We have made every effort to ensure that the information in the above is complete and accurate, but cannot guarantee this and accept no liability for errors or omissions.

Readers are advised that investing may involve a risk of loss that cannot be determined in advance, and that past performance and price development cannot be used as a reliable indicator of future performance and price development. For further information please contact info@borsgade.dk

You might also find this interesting:

Michael Mauboussin: Drawdowns Are The Unavoidable Cost of Long-Term Investing

June 6, 2025

Michael Mauboussin from Morgan Stanley Investment Management have published a comprehensive analysis examining stock market drawdowns and recovery patterns from 1985 to 2024. The research reveals that even the most successful investments experience severe price declines, with the median stock suffering an 85% drawdown that takes 2.5 years from peak to trough.

The study analyzed over 6,500 companies and found that more than half never recover to their previous highs. Michael’s work demonstrates that large drawdowns are an inevitable feature of equity investing, affecting individual stocks, mutual funds, and even portfolios with perfect foresight.

Thomas Gayner: My Current Take on Novo Nordisk

June 6, 2025

In his interview, Tom Gayner, CEO of Markel Group, reflects on investment principles shaped by Warren Buffett and Charlie Munger, and offers a detailed assessment of Novo Nordisk. Gayner praises Novo Nordisk for its business quality, global leadership in diabetes treatment, and strong growth trajectory. He credits the company’s disciplined management and innovation in pharmaceuticals as exemplary, aligning with his own standards of long-term value creation.

Michael Mauboussin: Put Expected Value In Your Valuation Toolkit

May 21, 2025

In this article, Michael Mauboussin explores how investors can generate excess returns by focusing on the gap between price and value, emphasizing the practicalities and psychology of expected value in investment decisions. He explains that while price is observable, value is inherently probabilistic, requiring careful estimation of possible payoffs and their probabilities.

The paper covers the challenges of modeling uncertainty, the importance of considering both probabilities and payoffs, the psychological hurdles investors face (like loss aversion), and best practices for applying these concepts across asset classes.

Bill Ackman: Success is Not A Straight Line Up

May 21, 2025

In the 2025 UBS Berkshire Hathaway Fireside Chat, Bill Ackman and Ryan Israel from Pershing Square Capital discuss investment philosophy, market volatility, the impact of tariffs and geopolitics, and lessons from Warren Buffett.

The conversation covers how to identify durable, high-quality businesses, the importance of long-term thinking, and the evolving landscape for activist investing. Ackman shares personal reflections on resilience, mentorship, and the role of free speech, while both speakers provide practical advice for young investors and fund managers.